Sanofi: Amundi amends disclosure of 5.7% passive stake
The reported position includes 30,319,386 shares in an employee investment vehicle whose voting rights are exercised by its supervisory board.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sanofi (SNY) ownership figures reported by Amundi and Amundi Asset Management show beneficial ownership of 68,832,052 shares, or 5.70% of the class. Both report shared voting power over 34,587,207 shares and shared dispositive power over 34,244,845 shares; sole voting and dispositive power are zero. The two reports show the same position figures.
Amundi states it does not have voting rights over 30,319,386 shares held through an FCPE dedicated to Sanofi group employee shareholding. The FCPE supervisory board exercises the associated voting rights, with employee representatives holding a majority.
Key Figures
Key Terms
beneficially owned financial
FCPE technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.